Short Interest in Applied Dna Sciences Inc (NASDAQ:BNBX) Decreases By 60.5%

Applied Dna Sciences Inc (NASDAQ:BNBX) saw a significant decrease in short interest during the month of June. As of June 15th, there was short interest totaling 55,360 shares, a decrease of 60.5% from the May 31st total of 140,122 shares. Approximately 0.8% of the company’s stock are sold short. Based on an average daily volume of 236,645 shares, the short-interest ratio is currently 0.2 days.

Applied Dna Sciences Stock Up 5.9%

Shares of BNBX traded up $0.02 during mid-day trading on Tuesday, reaching $0.37. 321,912 shares of the company’s stock were exchanged, compared to its average volume of 544,968. Applied Dna Sciences has a 52-week low of $0.32 and a 52-week high of $7.15. The stock has a market cap of $2.66 million, a PE ratio of -0.01 and a beta of 0.52. The stock’s fifty day simple moving average is $0.47.

Applied Dna Sciences (NASDAQ:BNBX) last issued its quarterly earnings results on Friday, May 15th. The company reported ($0.68) earnings per share (EPS) for the quarter. The company had revenue of $1.02 million during the quarter. Applied Dna Sciences had a negative net margin of 1,647.25% and a negative return on equity of 349.95%.

Analyst Ratings Changes

Separately, Weiss Ratings restated a “sell (e+)” rating on shares of Applied Dna Sciences in a research report on Friday, April 24th. One research analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the company has a consensus rating of “Sell”.

Applied Dna Sciences Company Profile

Applied DNA Sciences is a U.S.-based biotechnology company that develops and commercializes molecular-level solutions for product authentication, supply chain security and forensic identification. The company’s technologies apply unique DNA markers and laboratory testing methods to tag, track and verify the authenticity of goods and materials, with the goal of combating counterfeiting, diversion and fraud across complex supply chains.

Central to Applied DNA’s offering is a suite of proprietary DNA-based markers and associated assays that can be incorporated into inks, fibers, coatings and other substrates to create tamper-evident, forensic-grade identifiers.